Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Al-Haideri, M. Mohammad, T. A. M. Darvishzadehdeldari, S. Karbasi, Z. Alimohammadi, M. Faramarzi, F. Khorasani, S. Rasouli, A. Tahmasebi, S. Darvishi, M. Akhavan-Sigari, R.

Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Griffin, D. W. Pai Mangalore, R. Hoy, J. F. McMahon, J. H.

Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Gao, P. Kang, L. Y. Liu, J. Liu, M.

Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2-18 years: an updated systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Griffin, D. W. J. Pai Mangalore, R. Hoy, J. F. McMahon, J. H.

Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Berger, Matthew N. Mowbray, Ellen S. Farag, Marian W. A. Mathieu, Erin Davies, Cristyn Thomas, Claire Booy, Robert Forster, Angus H. Skinner, S. Rachel

Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis

  • All age groups
  • Safety
  • Acceptance
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Suteja, R. C. Salim, A. Suryanov, I. P. D. Tirtayasa, P. M. W. Duarsa, G. W. K.

Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Emmanouilidou-Fotoulaki, E. Karava, V. Dotis, J. Kondou, A. Printza, N.

Immunologic Response to SARS-CoV-2 Vaccination in Pediatric Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

  • Children
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Tafuri, S. Bianchi, F. P. Cuscianna, E. Rizzi, D. Signorile, N. Daleno, A. Migliore, G.

Impact of COVID-19 pandemic on flu vaccine uptake in healthcare workers in Europe: a systematic review and meta-analysis

  • Europe
  • Healthcare workers
  • Influenza
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Chaubey, I. Vijay, H. Govindaraj, S. Babu, H. Cheedarla, N. Shankar, E. M. Vignesh, R. Velu, V.

Impact of COVID-19 Vaccination on Pregnant Women

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Rosado, C. Fernandes, Â R. Rodrigues, A. G. Lisboa, C.

Impact of Human Papillomavirus Vaccination on Male Disease: A Systematic Review

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...